Herbas VPB

Print
EN | LT
LT - PROGESTERONE FORMULATIONS
EN - PROGESTERONE FORMULATIONS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/57 (2006.01)
A61K 31/57 (2013.01)
A61K 31/565 (2006.01)
A61K 9/1075 (2013.01)
A61K 47/14 (2017.01)
A61P 15/00 (2018.01)
A61P 5/34 (2018.01)
A61K 45/06 (2006.01)
A61K 47/10 (2017.01)
A61P 5/24 (2018.01)
A61K 9/107 (2006.01)
A61P 43/00 (2018.01)
A61K 9/48 (2006.01)
A61K 47/10 (2013.01)
A61K 31/565 (2013.01)
A61K 45/06 (2013.01)
A61P 15/12 (2018.01)
A61P 15/06 (2018.01)
A61K 47/14 (2013.01)
A61P 5/30 (2018.01)
A61K 9/48 (2013.01)
European patent
(11) Number of the document 3560500
(13) Kind of document T
(96) European patent application number 19163006.0
Date of filing the European patent application 2013-06-18
(97) Date of publication of the European application 2019-10-30
(45) Date of publication and mention of the grant of the patent 2021-12-22
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
201261661302 P 2012-06-18 US
201261662265 P 2012-06-20 US
201213684002 2012-11-21 US
PCT/US2013/023309 2013-01-25 WO
201313843362 2013-03-15 US
Inventors
(72)
CACACE, Janice Louise , US
PERSICANER, Peter H.R. , US
Grantee
(73) TherapeuticsMD, Inc. , 951 Yamato Road, Suite 220, Boca Raton, FL 33431, US
Title
(54) PROGESTERONE FORMULATIONS
  PROGESTERONE FORMULATIONS